180 related articles for article (PubMed ID: 24244668)
1. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size.
Lin ZZ; Shau WY; Hsu C; Shao YY; Yeh YC; Kuo RN; Hsu CH; Yang JC; Cheng AL; Lai MS
PLoS One; 2013; 8(11):e80276. PubMed ID: 24244668
[TBL] [Abstract][Full Text] [Related]
2. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
Chen S; Peng Z; Lin M; Chen Z; Hu W; Xie X; Liu L; Qian G; Peng B; Li B; Kuang M
Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yang B; Zan RY; Wang SY; Li XL; Wei ML; Guo WH; You X; Li J; Liao ZY
World J Surg Oncol; 2015 Mar; 13():96. PubMed ID: 25889181
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
6. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
[TBL] [Abstract][Full Text] [Related]
8. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
[TBL] [Abstract][Full Text] [Related]
9. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
Chang YJ; Chen LJ; Chang YJ; Chen PD
Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
[TBL] [Abstract][Full Text] [Related]
10. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.
Luo BM; Wen YL; Yang HY; Zhi H; Xiao XY; Ou B; Pan JS; Ma JH
World J Gastroenterol; 2005 Oct; 11(40):6277-80. PubMed ID: 16419155
[TBL] [Abstract][Full Text] [Related]
12. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey.
Hasegawa K; Kokudo N; Makuuchi M; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y
J Hepatol; 2013 Apr; 58(4):724-9. PubMed ID: 23178708
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma.
Azab M; Zaki S; El-Shetey AG; Abdel-Moty MF; Alnoomani NM; Gomaa AA; Abdel-Fatah S; Mohiy S; Atia F
Arab J Gastroenterol; 2011 Sep; 12(3):113-8. PubMed ID: 22055587
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial.
Brunello F; Veltri A; Carucci P; Pagano E; Ciccone G; Moretto P; Sacchetto P; Gandini G; Rizzetto M
Scand J Gastroenterol; 2008; 43(6):727-35. PubMed ID: 18569991
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case-control comparative analysis.
Yu SJ; Yoon JH; Lee JM; Lee JY; Kim SH; Cho YY; Yoo JJ; Lee M; Lee DH; Cho Y; Cho EJ; Lee JH; Kim YJ; Kim CY
Medicine (Baltimore); 2016 Aug; 95(35):e4551. PubMed ID: 27583865
[TBL] [Abstract][Full Text] [Related]
20. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
